Evaluating homologous recombination status and the efficacy/safety of PARP inhibitors in advanced epithelial ovarianl cancer: A single-institute preliminary experience. - Wu CH; Ou YC; Fu HC; Tsai CC; Wang YW; Chen YY; Huang SW; Lin H (Taiwanese journal of obstetrics & gynecology, 2026)